Anemia of Critical Illness: Prevention and Treatment 87 ANEMIA OF CRITICAL ILLNESS: PREVENTION AND TREATMENT Pharmacotherapy Self-Assessment Program, 5th Edition
نویسندگان
چکیده
1. Detect the pathophysiologic cause(s) of anemia in critically ill patients and assess the risks associated with its development. 2. Assess for the presence of anemia of critical illness in patients using clinical and laboratory indicators. 3. Assess the risks and benefits associated with the various treatment strategies for anemia of critical illness. 4. Develop patient-specific therapeutic plans for the management of patients with, or at risk for developing, anemia of critical illness. 5. Formulate both pharmacological and nonpharmacological strategies to prevent anemia of critical illness and conserve the use of blood products.
منابع مشابه
Comparing the Effectiveness of Schema Therapy Augmented Exposure and Response Prevention With Exposure and Response Prevention and Pharmacotherapy in Obsessive-compulsive Disorder
Objectives: Obsessive-compulsive disorder (OCD) is defined in the diagnostic and statistical manual of mental disorders, 5th Edition (DSM-5) as annoying and unpleasant thoughts or images (obsession) associated with repetitive and unwanted actions (compulsion). This study aims to compare emotional schema therapy augmented exposure and response prevention (ESTERP) with exposure and response preve...
متن کاملPREVENTION OF CARDIOVASCULAR DISEASE Pharmacotherapy Self-Assessment Program, 5th Edition
1. Distinguish among those preventive strategies that are primordial, primary, or secondary in the prevention of cardiovascular disease. 2. Develop a plan for a specific patient using primordial, primary, or secondary prevention strategies based upon published literature. 3. Given patient-specific information, develop and justify your treatment plan for the prevention of cardiovascular disease....
متن کاملHEALTH PROMOTION AND DISEASE PREVENTION Pharmacotherapy Self-Assessment Program, 5th Edition
1. Discuss the implications of the human genome project and the advent of pharmacogenomics for disease prevention and health promotion initiatives for substance abuse prevention. 2. Outline the Food and Drug Administration’s (FDA) five-part strategic action plan, Protect and Advance America’s Health. 3. Determine when pharmacotherapies are indicated for disease treatment and/or disease preventi...
متن کاملP180: The Effect of Complementary Medicine on Treatment and Prevention of MS Illness in Animal Model
Multiple Sclerosis is a chronic neurological disease that is accompanied by inflammation and myelin deficiency, and this pathological myelin disorder is irreversible. The prevalence of this disease is in 20-40 ages, and the rate of its prevalence in women is 1.7 times more than men. Yet, no effective medicine has been offered for this illness, and the present treatment methods are costly. Regar...
متن کاملThe Expert Patient: A New Approach to Type 2 Diabetes Self-Management based on Illness Perception and Embodied Cognition
Introduction: In new patient-training methods, the issue of patient empowerment has been presented which emphasizes the active role of patient in education and treatment. This study examined the impact of empowerment –based diabetes education (knowledge diabetes and embodied cognition) in promoting self-management behaviors in type 2 diabetic patients. Methods: This randomized clinical trial st...
متن کامل